Selling smoking cessation
Most people who have smoked for any signifi cant length of time would like to stop smoking. Findings from prospective studies examining the natural history of eff orts to stop smoking show that smokers often make frequent eff orts to stop smoking or reduce their consumption, with little long-term success. 1 Findings also show that most attempts to stop smoking are unplanned and are typically made without any professional assistance, even though eff ective support combining behavioural counselling and pharmacotherapy can substantially increase the odds of successfully remaining smoke-free. 2 In 1999-some 25 years after the fi rst smoking cessation clinic (the Maudsley Clinic) was established in London, UK, by Michael Russell-a process began to establish a national network of government-funded services to encourage and support smokers to stop smoking across the UK. These Stop Smoking Services (SSS) off er a comprehensive approach that provides ongoing (>4 weeks) specialist behavioural support, and access to either free or subsidised stop smoking medications. Evidence shows that the network of SSS is eff ective. 3, 4 Smoking prevalence within the UK has steadily declined from 27% in 2001 to 19% in 2013. 5 UK smokers are more likely to receive cessation support for any given quit attempt and more likely to succeed in that attempt compared with their counterparts in other countries. 6 However, only about half of smokers in the UK report using any type of support to quit, and the most commonly reported methods are electronic cigarettes and over-the-counter nicotine replacement therapy.
2 Less than 5% of smokers report using the SSS as a quit method, despite eff orts to increase referrals among health-care providers, although other tobacco control interventions that drive motivation to quit, such as mass media campaigns, have had funding reduced over the past few years. 7 Low attendance at SSS is a concern because evidence shows that these services are not only a highly cost-eff ective medical intervention producing higher quit rates than other approaches, but are also eff ective in reaching smokers from disadvantaged communities. 4, 8 In The Lancet, Hazel Gilbert and colleagues' randomised controlled Start2quit trial 9 addresses the issue of low and declining attendance at National Health Service SSS. The study was done in 18 SSS in England, with 99 general practices within the SSS areas, and compared two outreach approaches to encourage increased uptake among smokers: an individually tailored risk letter with an invitation to attend a no-obligation taster session (intervention) or a generic letter advertising the local SSS. 4383 smokers were enrolled and followed up for 6 months to determine their attendance at an SSS and establish their smoking status. Attendance at the fi rst session of an SSS course was signifi cantly higher in the intervention group than in the control group It is not possible to disentangle the eff ects of the tailored letter from those of the taster session, and they could work individually or synergistically. The tailored letter from a trusted health-care provider might serve as a powerful cue to action. The taster session might off er an opportunity to try out treatment without a fi rm commitment to change, and thus might represent a softer and potentially more eff ective approach for encouraging smokers to initiate treatment. Together, these strategies seem to heighten treatment engagement and ultimately increase the likelihood of quitting.
Almost 10% of smokers in the control group attended the SSS programme merely as a result of a generic referral letter. This fi nding shows the potential of proactively reaching out to large numbers of smokers. Proactive identifi cation and engagement of smokers is an eff ective strategy that could be more eff ective than reactive methods that rely on smokers to selfinitiate treatment. 10 Non-intensive proactive follow-up with smokers shortly after a visit with their provider is an inexpensive way to reinforce cessation advice provided during that visit. Technology-based strategies could enhance this outreach even further through any combination of text messaging, email, and automated telephone calls, each engineered to directly link smokers to a local SSS. 11 Outreach should also be extended to all smokers irrespective of whether or not they express an immediate interest in quitting. Motivation to quit can be transient and even induced through the same outreach methods as those described in Gilbert and colleagues' study. In fact, studies have reported benefi ts of engaging unmotivated smokers in treatment and catalysing the cessation process. 12 The robust and impressive fi ndings from the Start2quit trial provide clear evidence for how to improve the delivery of a highly cost-eff ective lifesaving medical intervention. The fi ndings also provide further support for the UK SSS overall. Government authorities should resist any cost-cutting suggestions to decrease support for the SSS on the basis of the obvious and well documented benefi ts achieved when smokers are enrolled in these services. 13 
